Stay updated with breaking news from Memory Diagnostic Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Food and Drug Administration has granted full approval to Leqembi for patients in the early stages of Alzheimer’s disease. Washington University School of Medicine's Barbara Joy Snider, MD, PhD, answers questions about the drug.
St. Louis City has the highest rate of Alzheimer’s dementia cases in Missouri, and new evidence from Washington University's School of Medicine shows that social factors like income, race and
Members of minoritized racial or ethnic groups and people who live in less affluent neighborhoods are less likely than others to receive specialized care for dementia, including Alzheimer’s disease, a new study from Washington University School of Medicine in St. Louis indicates.